Vivos (RDGL) Assets Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.78% |
| Sep 30, 2025 | 108.75% |
| Jun 30, 2025 | 56.09% |
| Dec 31, 2024 | 119.46% |
| Sep 30, 2024 | 44.57% |
| Jun 30, 2024 | 105.50% |
| Mar 31, 2024 | 89.00% |
| Dec 31, 2023 | 150.01% |
| Sep 30, 2023 | 166.15% |
| Jun 30, 2023 | 193.90% |
| Mar 31, 2023 | 363.27% |
| Dec 31, 2022 | 156.50% |
| Sep 30, 2022 | 133.39% |
| Jun 30, 2022 | 24.07% |
| Mar 31, 2022 | 120.53% |
| Dec 31, 2021 | 107.98% |
| Sep 30, 2021 | 92.52% |
| Jun 30, 2021 | 95.98% |
| Mar 31, 2021 | 51.37% |
| Dec 31, 2020 | 29.82% |
| Sep 30, 2020 | -7.05% |
| Jun 30, 2020 | 23.72% |
| Dec 31, 2019 | -13.49% |
| Sep 30, 2019 | 4.98% |
| Jun 30, 2019 | -31.04% |
| Mar 31, 2019 | -28.44% |
| Dec 31, 2018 | -39.43% |
| Sep 30, 2018 | -53.19% |
| Jun 30, 2018 | -55.39% |
| Mar 31, 2018 | -75.39% |
| Dec 31, 2017 | -57.80% |
| Sep 30, 2017 | -48.55% |
| Jun 30, 2017 | -15.73% |
| Mar 31, 2017 | -51.85% |
| Dec 31, 2016 | -48.11% |
| Sep 30, 2016 | -42.40% |
| Jun 30, 2016 | -44.54% |
| Dec 31, 2015 | -37.39% |